Valdemarsson Stig
Sektionen för endokrinologi/diabetes, Universitetssjukhuset i Lund.
Lakartidningen. 2004 Feb 5;101(6):458-65.
Prolactin is found in serum in different molecular forms differing in molecular size, i.e., monomeric prolactin (molecular mass 23 kDa), "big prolactin" (50-60 kDa, possibly a dimer or a complex with receptor) and "big, big prolactin" or "macroprolactin" (150-170 kDa), usually a complex with immunoglobulin G. Macroprolactin, generally considered to be biologically inactive, accounts for the major part of prolactin immunoreactivity in some patients. The concentration may be unchanged for many years. Different immunoassays for prolactin differ in reactivity with this macromolecular complex. Awareness of macroprolactin as a potential source of misdiagnosis is clinically important. However, as witnessed by results from measurements of a sample distributed by EQUALIS in 2001, and also by a recent inquiry, only a small minority of Swedish laboratories are capable to establish the presence of macroprolactin. Through efforts done by UK NEQAS, an increasing number of British laboratories now have this capacity. Laboratories performing prolactin measurements should have access to methodology to establish macroprolactinaemia. They also have a duty to inform patients' physicians about these problems and how they are solved.
催乳素在血清中以不同分子形式存在,分子大小各异,即单体催乳素(分子量23 kDa)、“大催乳素”(50 - 60 kDa,可能是二聚体或与受体的复合物)以及“大大催乳素”或“巨催乳素”(150 - 170 kDa),通常是与免疫球蛋白G的复合物。巨催乳素一般被认为无生物活性,在一些患者中占催乳素免疫反应性的主要部分。其浓度可能多年保持不变。不同的催乳素免疫测定法对这种大分子复合物的反应性有所不同。认识到巨催乳素是误诊的潜在来源在临床上很重要。然而,从2001年EQUALIS分发的一份样本的测量结果以及最近的一项调查来看,只有少数瑞典实验室能够检测出巨催乳素的存在。通过英国国家外部质量评估计划(UK NEQAS)的努力,现在越来越多的英国实验室具备了这种能力。进行催乳素测量的实验室应掌握检测巨催乳素血症的方法。他们还有义务告知患者的医生这些问题以及如何解决。